Defunct Company
Total Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
505
NCT00881946
Repeat Dose Safety Study for Compound to Treat Hematologic Cancer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 31, 2009
Completion: Mar 31, 2012
NCT01186068
Dose Response Study of Patients With Erythematous Rosacea
Phase: Phase 2
Role: Collaborator
Start: Aug 31, 2010
Completion: Not specified
NCT01202214
Repeat Dose Safety Study for Compound to Treat Asthma
Phase: Phase 1
Start: Sep 30, 2010
NCT01290133
Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV)
Start: May 31, 2011
Completion: Oct 31, 2011
NCT01424280
Single Dose Study of GSK1440115 in Patients With Asthma
Start: Aug 31, 2011
NCT01507194
A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)
Start: Feb 29, 2012
Completion: Aug 31, 2012
NCT01653912
Dose-finding Study in Platinum-Resistant Ovarian Cancer
Start: Nov 30, 2012
Completion: Nov 30, 2015